文献速递临床试验与 GCP基础与转化研究

激素敏感性前列腺癌骨转移患者的高强度抗阻与冲击训练:一项随机临床试验的研究方案

High-intensity resistance and impact training for patients with hormone-sensitive prostate cancer and bone metastases-study protocol of a randomized clinical trial.
PubMed 文献 · Trials · 2025-07-28

这是一项盲法随机对照试验方案,计划纳入102例前列腺癌骨转移患者,比较32周监督下高强度渐进抗阻与冲击训练(干预组)与标准治疗(对照组)的安全性和疗效,主要结局为30秒坐立试验测定的体能和下肢力量变化。

要点

  • 研究对象为前列腺癌骨转移患者,干预为32周监督下高强度渐进抗阻与冲击训练。
  • 主要结局为30秒坐立试验测定的体能和下肢力量变化,随访至44周。
  • 研究旨在探讨靶向骨骼的运动治疗对骨密度、安全性和生活质量的影响。

核心结论

  • 该研究是首个在前列腺癌骨转移患者中评估长期高强度渐进抗阻与冲击训练的研究。
  • 研究将揭示渐进抗阻与冲击训练在前列腺癌骨转移患者中的疗效和安全性,可能改善治疗相关副作用和生活质量。

研究设计与样本

  • 盲法随机对照试验,计划纳入102例前列腺癌骨转移患者。
  • 参与者被分配到监督下32周高强度渐进抗阻与冲击训练项目(干预组)或标准治疗包括可选的市政12周标准训练项目(对照组)。
  • 数据在基线、干预中期(16周)、干预后(32周)和随访(44周)收集。

主要发现

  • 主要结局为30秒坐立试验测定的体能和下肢力量变化。
  • 次要结局包括骨密度和身体成分、身体功能、生活质量、安全性(即不良事件和疼痛)、住院、体力活动、跌倒、可行性和患者体验。

关键数值与推荐

  • 干预组接受监督下32周高强度渐进抗阻与冲击训练。
  • 对照组接受标准治疗,包括可选的市政12周标准训练项目。
  • 数据收集时间点为基线、16周、32周和44周。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Men with metastatic prostate cancer are at an increased risk of metabolic syndrome, cardiovascular disease, and pathological fracture. The latter is both attributed to the cancer itself, bones are the most common site of metastases in prostate cancer, as well as the treatment with androgen deprivation therapy. Exercise therapy has been shown to be beneficial, but with uncertainty about its safety, applicability, and suitability for patients with prostate cancer and bone metastases. In these patients, we aim to investigate the safety and efficacy of exercise therapy that specifically targets bone in terms of bone density in the legs. METHODS/DESIGN: This blinded, randomized, controlled trial will include 102 patients with prostate cancer and bone metastases. Participants will be assigned to a supervised 32-week high-intensity progressive resistance and impact training program (intervention group) or standard treatment including a municipal 12-week standard training program, if desired (control group). Primary outcomes are changes in physical capacity and lower extremity strength measured by the 30-s Chair Stand Test. Secondary outcomes include bone mineral density and body composition, physical function, quality of life, safety (i.e., adverse events and pain), hospitalizations, physical activity, falls, feasibility, and patient experiences. Data will be collected at baseline, midway intervention (16 weeks), post-intervention (32 weeks), and follow-up (44 weeks). DISCUSSION: This study is the first to examine a long-term high-intensity progressive resistance and impact training in patients with prostate cancer and bone metastases. While exercise recommendations for these patients have typically been cautious, high-intensity progressive resistance and impact training has demonstrated safety and benefit in patients with osteoporosis. This research will shed light on the efficacy and safety of progressive resistance and impact training in patients with prostate cancer and bone metastases, potentially improving treatment-related side effects and quality of life. TRIAL REGISTRATION: This trial is approved by the Regional Ethics Committee for the Capital Region of Denmark (J.nr.:H-23015286) and by the Danish Data Protection Agency (j.nr.: P-2023-2018). The study was prospectively registered at ClinicalTrials.gov on February 24, 2024 (ID: NCT06259279).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ragle AM, Mikkelsen MK, Vinther A, et al. High-intensity resistance and impact training for patients with hormone-sensitive prostate cancer and bone metastases-study protocol of a randomized clinical trial. Trials. 2025. PMID: 40722114. doi:10.1186/s13063-025-08937-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。